证券代码：002942 证券简称：新农股份 公告编号：2023-034 浙江新农化工股份有限公司 关于部分募集资金投资项目延期的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 浙江新农化工股份有限公司（以下简称"公司"）于 2023 年 8 月 22 日召开第 六届董事会第五次会议、第六届监事会第五次会议审议通过《关于部分募集资金 投资项目延期的议案》，在募投项目实施主体、募集资金投资用途及投资规模不 发生变更的情况下，根据目前项目的实施进度，将"年产 1,000 吨吡唑醚菌酯及 副产 430 吨氯化钠项目"达到预定可使用状态的日期进行延期。 根据《深圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规范 运作》的相关规定，本议案不涉及实施主体、募集资金投资用途及投资规模变更， 无需提交公司股东大会审议。具体内容公告如下： 一、募集资金基本情况 注："截止 2023.6.30 募集资金实际累计投入金额"超出"调整后的投资总额"系使用的 募集资金理财收益及存款利息。 经中国证券监督管理委员会《关于核准浙江新农化工股份有限公司首次公开 发行股票的批复 ...

浙江新农化工股份有限公司独立董事 关于第六届董事会第五次会议相关事项的 独立意见 我们同意公司本次对部分募集资金投资项目延期。 根据《中华人民共和国公司法》、《上市公司独立董事规则》、《深圳证券交易 所上市公司自律监管指引第 1 号——主板上市公司规范运作》及《浙江新农化工 股份有限公司章程》等相关规定，我们作为浙江新农化工股份有限公司（以下简 称"公司"）的独立董事，本着认真、负责的态度，对公司第六届董事会第五次会 议相关事项进行了审议，现基于独立判断立场，发表独立意见如下： 一、关于控股股东及其他关联方占用资金及对外担保情况的专项说明和独 立意见 根据《上市公司监管指引第 8 号——上市公司资金往来、对外担保的监管要 求》、《深圳证券交易所股票上市规则》及《公司章程》等有关规定，我们本着对 公司、全体股东负责的态度，按照实事求是的原则对公司控股股东及其他关联方 占用资金的情况和对外担保情况进行了认真的检查和落实，对公司进行了必要的 核查和询问后，发表独立意见： 经核查，2023 年上半年，公司不存在控股股东及其他关联方非经营性占用 公司资金的情况；公司不存在对外担保的情况，亦不存在对控股股东及其他关联 方 ...

证券代码：002942 证券简称：新农股份 公告编号：2023-030 浙江新农化工股份有限公司 第六届董事会第五次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 浙江新农化工股份有限公司（以下简称"公司"）第六届董事会第五次会议于 2023 年 8 月 22 日在公司会议室以现场结合通讯方式召开。本次董事会已于 2023 年 8 月 17 日以专人送达、电子邮件、电话等方式通知公司全体董事、监事、高 级管理人员。会议由公司董事长徐群辉先生主持，会议应出席董事 9 名，实际出 席董事 9 人，其中独立董事刘亚萍女士，董事徐月星先生、泮玉燕女士通过通讯 方式出席会议。本次会议的召集、召开及表决程序符合有关法律、行政法规、部 门规章、规范性文件及《公司章程》的规定。 二、董事会会议审议情况 （一）审议通过《关于 2023 年半年度报告及摘要的议案》； 公司已严格按照相关法律、法规及中国证监会的规定，根据公司 2023 年半 年度实际经营情况编制了公司《2023 年半年度报告》及《2023 年半年度报告摘 要》，报告内容真实、准 ...

证券代码：002942 证券简称：新农股份 公告编号：2023-035 浙江新农化工股份有限公司 关于使用募集资金向全资子公司江苏新农化工有限 公司增资的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 浙江新农化工股份有限公司（以下简称"公司"）于 2023 年 8 月 22 日召开第 六届董事会第五次会议、第六届监事会第五次会议审议通过《关于使用募集资金 向全资子公司江苏新农化工有限公司增资的议案》，同意公司使用募集资金 195,390,714.37 元向全资子公司江苏新农化工有限公司进行增资，用于募投项目 "年产 1,000 吨吡唑醚菌酯及副产 430 吨氯化钠项目"的实施。 根据《深圳证券交易所股票上市规则》和《公司章程》等相关规定，公司本 次使用募集资金对全资子公司进行增资，增资金额在公司董事会审批权限内，无 需提交股东大会审议批准。本次增资未构成关联交易，也未构成《上市公司重大 资产重组管理办法》规定的重大资产重组。具体内容公告如下： 一、募集资金基本情况 三、使用募集资金向全资子公司增资的情况 1、本次增资计划概述 公司在募投项目实施之初，采 ...

证券代码：002942 证券简称：新农股份 公告编号：2023-036 浙江新农化工股份有限公司 2023 年半年度募集资金存放与使用情况的专项报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 根据中国证监会发布的《上市公司监管指引第 2 号——上市公司募集资金 管理和使用的监管要求》（2022 年修订）和深圳证券交易所颁布的《深圳证券 交易所股票上市规则》、《深圳证券交易所上市公司自律监管指引第 1 号—— 主板上市公司规范运作》和《浙江新农化工股份有限公司募集资金管理制度》 的有关规定，现将本公司 2023 年半年度募集资金存放与使用情况报告如下： 一、募集资金基本情况 （一）募集资金金额及到位时间 根据公司 2017 年 3 月 23 日召开的 2017 年第一次临时股东大会审议，并经 中国证券监督管理委员会《关于核准浙江新农化工股份有限公司首次公开发行 股票的批复》（证监许可［2018］1604 号）的核准，公司向社会公开发行了人 民币普通股(A 股)股票 3,000 万股，发行价为每股人民币为 14.33 元，共计募集 资金总额为人民币 42,9 ...

证券代码：002942 证券简称：新农股份 公告编号：2023-021 浙江新农化工股份有限公司（以下简称"公司"）《2022 年年度报告》全文及 其摘要、《2023 年第一季度报告》已于 2023 年 4 月 28 日在公司指定信息披露媒 体《证券时报》和巨潮资讯网（www.cninfo.com.cn）上披露。为便于广大投资者 更深入、全面地了解公司的经营业绩、发展战略等情况，公司定于 2023 年 5 月 17 日（星期三）15:00-17:00 采用网络方式举办 2022 年度暨 2023 年第一季度网 上业绩说明会，具体情况如下： 浙江新农化工股份有限公司 关于举行 2022 年度暨 2023 年第一季度 网上业绩说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 重要内容提示： 会议召开时间：2023 年 5 月 17 日（星期三）15:00-17:00 会议召开方式：网络互动方式 会议召开地点：价值在线（www.ir-online.cn） 会议问题征集：投资者可于 2023 年 5 月 17 日（周三）前访问网址 https://eseb ...

Financial Performance - The company's operating revenue for 2022 was ¥1,248,167,151.74, an increase of 7.36% compared to ¥1,162,570,966.46 in 2021 [21]. - The net profit attributable to shareholders for 2022 was ¥101,410,374.57, a decrease of 26.45% from ¥137,873,663.39 in 2021 [21]. - The net profit after deducting non-recurring gains and losses was ¥91,869,007.68, down 22.56% from ¥118,628,109.74 in 2021 [21]. - The net cash flow from operating activities was ¥138,071,733.77, a decline of 34.73% compared to ¥211,552,468.06 in 2021 [21]. - The total assets at the end of 2022 were ¥1,640,813,247.21, reflecting a growth of 5.66% from ¥1,552,881,288.43 at the end of 2021 [21]. - The weighted average return on equity decreased to 8.79% in 2022, down 3.55 percentage points from 12.34% in 2021 [21]. - The total revenue for 2022 was CNY 1,248.17 million, representing a year-on-year increase of 7.36% [69]. - The pesticide sector generated CNY 1,212.62 million in revenue, up 8.33% from the previous year, making up 97.15% of total revenue [69]. - The company's gross margin in the pesticide sector decreased by 5.53 percentage points to 25.13% [72]. Risk Management - The company emphasizes the importance of risk awareness regarding environmental risks and market competition risks that may lead to profit decline [4]. - The company has a comprehensive risk management strategy in place to address potential risks [4]. - The company's financial performance and future outlook are subject to market conditions and investor awareness of risks [4]. - The risk management strategy includes a focus on hedging against currency fluctuations, which has been effective in mitigating potential losses [99]. - The company faces market competition risks, with 1,705 pesticide manufacturers in China, and plans to enhance product innovation and efficiency to mitigate these risks [130]. - Raw material price fluctuations pose a significant risk to the company's operating results, and the company will strengthen procurement controls to manage costs [131]. Corporate Governance - The company has a governance structure that includes a board of directors with independent members, ensuring effective decision-making and risk management [141]. - The company maintains complete independence in assets, personnel, finance, organization, and business from its controlling shareholders and actual controllers [143]. - The company has a dedicated financial department with an independent accounting system, ensuring autonomous financial decision-making and tax compliance [146]. - The company has a complete business system with independent production, supply, sales, and R&D capabilities, avoiding any unfair related transactions with controlling shareholders [148]. - The company held four shareholder meetings during the reporting period, with investor participation rates of 72.98%, 71.37%, 73.06%, and 71.52% respectively [149]. Research and Development - The company has a complete research and development, production, and sales system, allowing for independent operation based on customer needs [39]. - The company is actively engaged in research and development of new products and technologies to strengthen its market position [47]. - The company has established a comprehensive R&D system through collaborations with universities and research institutions [65]. - The company invested CNY 70.24 million in R&D during the reporting period, accounting for 5.63% of total revenue [65]. - Research and development expenses decreased by 7.24% to ¥70,237,536.36, accounting for 5.63% of operating revenue [84]. Environmental Compliance - The company strictly adheres to environmental protection laws and regulations, including the Environmental Protection Law of the People's Republic of China [190]. - The company has established a series of environmental management systems and emergency response plans for pollution incidents, ensuring compliance with national laws and industry standards [194]. - The wastewater treatment system includes a new catalytic wet oxidation pre-treatment facility, which has been operational since 2021, ensuring compliance with discharge standards [195]. - The company has implemented a two-stage waste gas treatment process, utilizing resin adsorption and UV photocatalytic oxidation for pre-treatment, followed by centralized treatment to meet emission standards [196]. - The company has installed an online monitoring system for major pollutants such as sulfur dioxide and nitrogen oxides at the waste gas discharge outlet, enhancing real-time monitoring capabilities [197]. Market Strategy - The company is focused on expanding its production capabilities and enhancing its product offerings in the pesticide sector [46]. - The company is expanding its market presence through strategic acquisitions and partnerships, aiming for a 10% increase in market share by the end of the fiscal year [99]. - The company plans to enhance its marketing management and expand its product line, focusing on core crops and strategic new products [123]. - The company aims to become a leading agricultural technology enterprise in China, focusing on differentiated strategies and integrating chemical and biological pesticides [122]. - The company is exploring strategic acquisitions to enhance its market position and expand its product offerings in the chemical sector [109]. Shareholder Returns - The company reported a total share capital of 156,000,000 shares as of December 31, 2022, with a cash dividend of 2.50 RMB per 10 shares to all shareholders [5]. - The company has a total of 153,209,930 shares eligible for dividend distribution after accounting for repurchased shares [5]. - The total cash dividend for 2022, including other methods such as share repurchase, amounts to 42,820,272.80 CNY, representing 100% of the distributable profit of 541,922,894.87 CNY [177]. - The company has established a clear profit distribution policy in accordance with relevant regulations, ensuring shareholder interests are maintained [176]. - There were no adjustments made to the existing profit distribution policy during the reporting period, despite the company being profitable [177].

Financial Performance - The company's revenue for Q1 2023 was ¥275,296,537.41, a decrease of 11.16% compared to ¥309,867,486.10 in the same period last year[5] - Net profit attributable to shareholders was ¥10,792,398.23, down 70.41% from ¥36,471,489.16 year-on-year[5] - Basic and diluted earnings per share were both ¥0.07, a decrease of 69.57% from ¥0.23 in the same period last year[5] - The company reported a net profit margin of approximately 2.4% for Q1 2023, down from 13.3% in the previous year[18] - In Q1 2023, the net profit of Zhejiang Xinong Chemical Co., Ltd. was CNY 10,792,398.23, a decrease of 70.4% compared to CNY 36,471,489.16 in Q1 2022[19] - The total revenue from operating activities was CNY 227,429,761.91, slightly down from CNY 231,668,313.99 in the previous year[21] - The company reported a total comprehensive income of CNY 12,205,073.17, down from CNY 39,706,835.02 in Q1 2022[20] Cash Flow and Assets - The net cash flow from operating activities was -¥54,289,133.02, compared to -¥20,578,020.79 in the previous year, indicating a significant decline[10] - Cash and cash equivalents decreased to CNY 106,838,210.58 from CNY 153,244,257.70 at the beginning of the year, representing a decline of 30.4%[15] - The cash and cash equivalents at the end of the period were CNY 69,896,449.77, down from CNY 101,961,527.55 at the end of Q1 2022[22] - The company incurred a total of CNY 281,718,894.93 in cash outflows from operating activities, compared to CNY 252,246,334.78 in Q1 2022[21] - The investment activities generated a net cash flow of CNY 10,022,473.02, recovering from a negative cash flow of CNY -4,587,958.59 in the previous year[22] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,591,215,090.44, down 3.02% from ¥1,640,813,247.21 at the end of the previous year[5] - Total assets as of March 31, 2023, were CNY 1,591,215,090.44, down from CNY 1,640,813,247.21 at the beginning of the year, indicating a decrease of 3.0%[17] - Total liabilities decreased to CNY 407,236,799.52 from CNY 469,544,003.54, a decline of 13.3%[17] - The company's equity attributable to shareholders increased to CNY 1,183,978,290.92 from CNY 1,171,269,243.67, an increase of 1.0%[17] Operational Costs and Expenses - Total operating costs for Q1 2023 were CNY 269,917,998.89, slightly up from CNY 268,448,068.54 year-on-year[18] - The company’s income tax expense decreased by 80.74% to ¥1,631,804.35, reflecting a reduction in profit[10] - The company’s tax expenses for the quarter were CNY 1,631,804.35, significantly lower than CNY 8,470,415.10 in the same period last year[19] - Research and development expenses increased to CNY 18,524,154.33, up from CNY 17,330,948.12, indicating a focus on innovation[19] Market Strategy - The company plans to focus on expanding its market presence and enhancing product development in the upcoming quarters[16] Other Financial Metrics - The weighted average return on equity was 0.92%, a decrease of 2.23 percentage points from 3.15% in the previous year[5] - The company experienced a 54.84% increase in prepayments, totaling ¥14,464,308.22, primarily due to increased advance payments to suppliers[10] - The company reported a significant increase in derivative financial assets, rising 237.73% to ¥684,823.00 due to changes in the fair value of forward foreign exchange products[9] - Accounts receivable increased to CNY 167,261,948.75 from CNY 137,657,884.84, reflecting a growth of 21.5%[16] - Inventory decreased to CNY 148,935,962.85 from CNY 155,178,107.63, a reduction of 4.0%[16]

Financial Performance - The company's revenue for Q3 2022 reached ¥316,512,220.96, representing a 25.35% increase year-over-year[5] - Net profit attributable to shareholders decreased by 16.20% to ¥20,766,125.92 for Q3 2022, while the net profit excluding non-recurring items increased by 7.52% to ¥22,978,434.64[5] - Total operating revenue for the current period reached ¥1,018,031,597.00, an increase of 17.1% compared to ¥869,188,652.37 in the previous period[17] - Net profit for the current period was ¥119,678,202.06, reflecting a slight increase of 1.4% from ¥118,025,665.35 in the previous period[18] - Total profit for the current period was ¥136,793,844.45, a slight increase from ¥134,030,548.86 in the previous period[18] - The company’s total comprehensive income for the current period was ¥130,990,425.88, slightly up from ¥130,389,083.78 in the previous period[18] Assets and Liabilities - Total assets increased by 10.13% to ¥1,710,242,875.92 compared to the end of the previous year[5] - The company's total assets as of September 30, 2022, are CNY 1,710,242,875.92, an increase from CNY 1,552,881,288.43 at the beginning of the year[15] - The total current assets amount to CNY 958,792,891.94, up from CNY 872,093,066.83 at the beginning of the year[14] - The total non-current assets are CNY 751,449,983.98, compared to CNY 680,788,221.60 at the start of the year[15] - The total liabilities as of September 30, 2022, are CNY 520,639,399.41, an increase from CNY 413,485,841.39 at the beginning of the year[15] Shareholder Information - The total number of common shareholders at the end of the reporting period is 8,374[12] - Zhejiang Xinhui Investment Co., Ltd. holds 54.50% of the shares, amounting to 85,020,000 shares[12] - The company's equity attributable to shareholders is CNY 1,189,603,476.51, up from CNY 1,139,395,447.04[16] - The company has a total of 0 preferred shareholders at the end of the reporting period[13] Cash Flow - The company reported a net cash flow from operating activities of ¥179,932,690.68, an increase of 10.37% year-to-date[5] - Operating cash flow net amount was ¥179,932,690.68, an increase of 10.8% compared to ¥163,032,297.12 in the last period[20] - The company reported a net cash outflow from investing activities of ¥93,963,858.95, an improvement from a net outflow of ¥174,715,222.98 in the previous period[20] - The net cash flow from investing activities improved by 46.22%, reducing the outflow to ¥93,963,858.95[11] Expenses - Total operating costs amounted to ¥889,695,620.48, up 18.6% from ¥750,314,146.59 in the prior period[17] - Research and development expenses decreased to ¥54,044,201.97 from ¥61,074,669.79, a reduction of 11.5%[17] - The company's financial expenses showed a significant negative change of 503.77%, primarily due to exchange rate fluctuations resulting in foreign exchange gains[10] Equity and Returns - The company’s total equity attributable to shareholders increased by 4.41% to ¥1,189,603,476.51 compared to the end of the previous year[5] - The weighted average return on equity decreased by 0.4 percentage points to 1.76% for Q3 2022[5] - Basic and diluted earnings per share for the current period were both ¥0.7672, compared to ¥0.7566 in the previous period, indicating a growth of 1.4%[18] Accounts Receivable - Accounts receivable rose by 69.89% to ¥183,103,891.73, attributed to expanded sales and the activation of annual credit lines[10] - The accounts receivable increased to CNY 183,103,891.73 from CNY 107,779,711.28 at the beginning of the year[14] Cash and Cash Equivalents - Cash and cash equivalents at the end of the period totaled ¥117,362,762.94, down from ¥134,941,277.82 in the previous period[20] - The cash and cash equivalents amount to CNY 170,343,852.24, compared to CNY 161,706,358.07 at the beginning of the year[14]

Financial Performance - The company's operating revenue for the first half of 2022 was ¥701,519,376.04, representing a 13.76% increase compared to ¥616,683,917.39 in the same period last year[21]. - The net profit attributable to shareholders of the listed company was ¥98,912,076.14, up 6.08% from ¥93,245,955.15 in the previous year[21]. - The net cash flow from operating activities increased by 60.06% to ¥98,321,963.84, compared to ¥61,428,044.55 in the same period last year[21]. - The total assets at the end of the reporting period were ¥1,689,705,220.62, an increase of 8.81% from ¥1,552,881,288.43 at the end of the previous year[21]. - The net assets attributable to shareholders of the listed company were ¥1,163,994,615.77, reflecting a 2.16% increase from ¥1,139,395,447.04 at the end of the previous year[21]. - Basic earnings per share rose to ¥0.63, a 5.00% increase from ¥0.60 in the same period last year[21]. - The diluted earnings per share also increased to ¥0.63, up 5.00% from ¥0.60 in the previous year[21]. - The weighted average return on net assets was 8.32%, slightly down from 8.39% in the previous year[21]. Revenue and Market Growth - The company achieved operating revenue of 701.52 million yuan, representing a year-on-year growth of 13.76%[29]. - The net profit attributable to the parent company was 98.91 million yuan, with a year-on-year increase of 6.08%[29]. - The industrial products business revenue reached 421 million yuan, showing a year-on-year growth of 19.61%[30]. - The company reported a significant increase in foreign sales, with revenue from international markets reaching ¥189,386,147.06, up 13.79% from the previous year[60]. - The company plans to launch two new product lines in the next quarter, focusing on eco-friendly agricultural chemicals, aiming to capture a larger market share[133]. - Future outlook remains positive, with management guiding for a revenue target of 3 billion yuan for the full year, reflecting an anticipated growth rate of 20%[133]. Research and Development - Research and development investment amounted to 36.08 million yuan, with a total of 79 patent certificates obtained[31]. - The company is investing 50 million yuan in R&D for new technologies aimed at improving product efficacy and sustainability[133]. - The company has developed several key projects under national technology plans, including the clean production process of Thiazole Zinc and the industrialization of various pesticide formulations, achieving domestic leading and internationally advanced production technology[49]. Environmental and Safety Management - The company has established a complete safety and environmental management system, enhancing its management level[32]. - The company is committed to sustainable development and has implemented strict monitoring mechanisms for safety and environmental responsibilities[32]. - The company emphasizes safety and environmental protection, implementing a comprehensive management system and developing green synthesis processes that have won national awards[56]. - The company has implemented measures to ensure that its emissions of ammonia nitrogen and chemical oxygen demand are within regulatory limits[108]. - The company has installed a resin pre-treatment system, MVR concentration system, and a biochemical treatment system to enhance wastewater treatment capabilities[112]. - The company conducts regular emergency drills for environmental incidents, with at least two drills per year to ensure preparedness[117]. Market Competition and Risks - The company acknowledges risks such as environmental and market competition that may impact profit margins[3]. - The company faces market competition risks due to the presence of over 2,000 domestic pesticide manufacturers, including more than 500 raw material producers, which intensifies competition[96]. - The company is at risk of raw material price fluctuations, which significantly impact operating costs and gross margins, and plans to enhance procurement control to mitigate these risks[97]. Shareholder and Corporate Governance - The company plans not to distribute cash dividends or issue bonus shares[4]. - The company has committed to not transferring or entrusting the management of its shares for 36 months post-IPO, with a limit on share reduction not exceeding 1% of total shares within three months after the lock-up period[130]. - The company will publicly disclose reasons for any failure to fulfill commitments made in the prospectus and will apologize to shareholders and investors[136]. Subsidiary Performance - The subsidiary Taizhou Xinnong Technology Co., Ltd. achieved operating income of 234.18 million yuan and net profit of 14.53 million yuan during the reporting period[90]. - The subsidiary Jiangsu Xinnong Chemical Co., Ltd. reported operating income of 167.66 million yuan and net profit of 4.87 million yuan[92]. - The subsidiary Zhejiang Xinnong Chemical Sales Co., Ltd. generated operating income of 198.30 million yuan and net profit of 4.46 million yuan[93].